ARASTATIN

Live / Applied — Response to non-final action entered (as of 03 Nov 2026)

What this means for you

Not registered yet, but its 26 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79448312
Mark type
Word mark
Filed
26 Nov 2025
Attorney of record
Catherine F. Hoffman

Goods and services

  • Class 001 — Chemicals: Chemical, biochemical, biological and molecular genetic products intended for laboratory analysis, industry and science namely, chemicals for use in industry and science, biochemical preparations for scientific purposes, Biological preparations for use in industry and science, assays and reagents for use in genetic research; bioactive reagents and compounds namely, diagnostic reagents and preparations, except for medical or veterinary use; peptide substrates for scientific purposes; peptide derivatives in the nature of peptide substrates for scientific purposes, proteins in raw material form for scientific and medical research, glycans being chemicals for use in industry and science, nucleotides for scientific and medical research use, lipids used in the manufacture of cosmetics, beverages, food products and food supplements, monoclonal antibodies for scientific purposes, antibody-active principle conjugates in the nature of antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes, antibody fragments in the nature of antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes, antibody derivatives in the nature of antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes, nucleic acids other than for medical or veterinary purposes, DNA being diagnostic preparations for in vitro testing for scientific use, viral vectors for research purposes; chemical, biochemical, biological, biotechnological and molecular genetic preparations in the nature of assays and reagents for use in genetic research for industrial and scientific use; chemical, biological, biotechnological and molecular genetic preparations, namely polypeptides for in vitro research use and industrial proteins for reagent development or production for industrial and scientific applications; chemical, biological, biotechnological and molecular genetic preparations, namely polypeptides and proteins for reagent development or production for industrial and scientific applications; biological preparations, namely polypeptides for in vitro research use, peptide derivatives in the nature of peptide substrates for scientific purposes and industrial proteins for laboratories and analysis for industrial and scientific applications; chemical and biochemical substances for use in the manufacture of pharmaceuticals.
  • Class 005 — Pharmaceuticals: Pharmaceutical products namely, pharmaceutical preparations for the treatment of oncology, immunology, inflammation, infectious diseases, cardiovascular and metabolism diseases; medical preparations for the treatment of oncology, immunology, inflammation, infectious diseases, cardiovascular and metabolism diseases; pharmaceuticals and medical preparations in the field of cancer therapy; pharmaceuticals for treatment of cancer and medical preparations in the field of cancer therapy for treatment of cancer; biopharmaceuticals and medical preparations in the field of active antibody conjugates for the treatment of oncology, immunology, inflammation, infectious diseases, cardiovascular and metabolism diseases; chemical, biological, molecular genetic and biochemical and biopharmaceutical products for medical, pharmaceutical use, namely synthetic peptides for the treatment of oncology, immunology, inflammation, infectious diseases, cardiovascular and metabolism diseases, diagnostic preparations for medical or veterinary purposes in the nature of peptide derivatives being substrates, proteins arrays for medical diagnosis purposes, antibodies for medical purposes, active antibody conjugates being antibodies for medical purposes, antibody fragments being antibodies for medical purposes, antibody derivatives being antibodies for medical purposes, nucleic acids for medical or veterinary purposes, DNA being diagnostic preparations for in vitro testing for medical use, viral vector vaccines; pharmaceutical products and substances for the treatment of diseases and medical preparations for medical treatments.
  • Class 035 — Advertising and business services: Providing business information with respect to business contacts for research projects.
  • Class 042 — Scientific and technological services: Scientific and technological services as well as research work and design services relating thereto, namely, scientific research services provided by scientists dedicated to the chemical and technological study of biological molecules; scientific research, medical research, biological research, molecular genetic scientific research, chemical research, pharmaceutical research and technological research, in the field of biochemistry or pharmacy; scientific, medical, biological, molecular genetic research in the nature of scientific research in the field of genetics, chemical, pharmaceutical and technological research, in the field of biochemistry or pharmacy; scientific laboratory services of a biochemical or pharmaceutical laboratory; industrial analysis and research services in the field of pharmaceutical science; development and research experimentation of medicines; medical and scientific research, namely conducting preclinical and clinical trials for others; laboratory services for the benefit of third parties, namely, medical research laboratory services; scientific research advisory services in the biochemical, biological and molecular genetic fields; scientific research advice for the pharmaceutical industry sector; scientific research analysis services for medical and pharmaceutical research services in connection with the treatment of individuals; provision of scientific research information; provision of scientific research results, namely, data analysis of clinical trials.

Owner

Prosecution history

  • 03 Nov 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 03 Nov 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 03 Nov 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 28 Jul 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 28 Jul 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 28 Jul 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 28 Jul 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 25 Jun 2026 — REFUSAL PROCESSED BY IB
  • 11 Jun 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
  • 11 Jun 2026 — REFUSAL PROCESSED BY MPU
  • 28 Apr 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
  • 27 Apr 2026 — NON-FINAL ACTION WRITTEN
  • 23 Apr 2026 — ASSIGNED TO EXAMINER
  • 22 Apr 2026 — APPLICATION FILING RECEIPT MAILED
  • 22 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

View this trademark record on Rightsy